← All organizations

Estudios Clínicos Latino América

Academic/Hospital

Also known as: ECLA- Estudios Clínicos Latino América | ECLA- ICR | Estudios Clínicos Latino América

Highest phase reached

Phase 3

First clinical trial

Mar 31, 2020

Last known activity

Aug 14, 2020

Timeline

No events for the selected filters.

Drugs by trial phase (2 distinct, 2 trials)

Phase 3 (2 own, 0 via acquisition)

Recent trials (4)

  • NCT04460651Lead sponsorPhase 3Aug 14, 2020
  • NCT04460651Overall official - principal investigatorPhase 3Aug 14, 2020
  • NCT04328480Lead sponsorPhase 3Mar 31, 2020
  • NCT04328480Overall official - principal investigatorPhase 3Mar 31, 2020

Details

Last known activity
Aug 14, 2020